The Latest in Schizophrenia & Other Psychotic Disorders

Clinical Psychiatry News

New data support electroconvulsive therapy for severe depression

May 16, 2022

Clinical Psychiatry News

Do psychotropic meds raise or lower COVID risk in psych patients?

May 12, 2022

Clinical Psychiatry News

Higher ‘chemical restraint’ rates in Black psych patients in the ED

May 2, 2022

Current Psychiatry

Cats, toxoplasmosis, and psychosis: Understanding the risks

May 2, 2022

Schizophrenia & Other Psychotic Disorders

Clinical Psychiatry News

Virtual reality therapy promising for agoraphobia

April 26, 2022

Clinical Psychiatry News

High antipsychotic switch rates suggest ‘suboptimal’ prescribing for first-episode psychosis

April 25, 2022

Clinical Psychiatry News

New combination med for severe mental illness tied to less weight gain

April 25, 2022

Clinical Psychiatry News

Mental illness tied to COVID-19 breakthrough infection

April 21, 2022

Clinical Psychiatry News

‘Fragmented’ speech patterns may predict psychosis relapse

April 15, 2022

Schizophrenia & Other Psychotic Disorders

Clinical Psychiatry News

Novel long-acting injection cuts schizophrenia relapse

April 14, 2022

Schizophrenia & Other Psychotic Disorders

Clinical Psychiatry News

A new target in schizophrenia treatment: Brain gamma oscillations

April 13, 2022

Schizophrenia & Other Psychotic Disorders

Clinical Psychiatry News

FDA okays first sublingual med for agitation in serious mental illness

April 11, 2022

Clinical Psychiatry News

Metacognitive training an effective, durable treatment for schizophrenia

April 8, 2022

Schizophrenia & Other Psychotic Disorders

Clinical Psychiatry News

Psychotropic med use tied to ‘striking’ post-COVID dementia risk

March 30, 2022

Clinical Psychiatry News

Older adults with schizophrenia need ‘person-centered’ care

March 25, 2022